Inherited Genomics
What is Hemato-Oncology Testing?
Hemato-oncology testing identifies genetic mutations that may contribute to blood cancers and related hematological disorders, helping patients understand their risks and treatment options.
Who Should Consider This Testing?
Individuals with a family history of blood cancers.
Patients diagnosed with blood-related cancers, like leukemia or lymphoma.
Benefits of Hemato-Oncology Genetic Testing
Targeted Treatment: Identify genetic markers that can guide treatment.
Risk Management: Helps in planning preventive measures and monitoring.